News

World

Audio News

News

World

Audio News
Fews App News List News List

Why Wall Street sees a $39,800 pancreatic cancer pill as proof of a much bigger bet

Wall Street
Fortune Fews App News Provider
Fews App Post Time 6h ago

Source: Fortune

Dr. Danish Nagda, a shareholder in the developer, told Fortune it was "incredibly exciting . .

Go to Source
Related News
Fews App Loading
Login
Facebook Login
Twitter Login
Google Plus Login
Thank you for subscribing our newsletter
Your email has already been added to our subscibers list
Invalid email